NervGen Pharma Corp. — Company profile
Other · Canada
Last price 1.37 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 147.31M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company’s lead product candidate is NVG-291 that is in Phase 1b/2a clinical trial for the treatment of spinal cord injuries (SCI), stroke, multiple sclerosis, and Alzheimer’s disease; and NVG-300, which is in a preclinical model of ischemic stroke, amyotrophic lateral sclerosis, and confirmatory SCI study. NervGen Pharma Corp. has a licensing agreement with Case Western Reserve University to develop and commercialize a patented technology with therapeutic potential for spinal cord injury and other conditions associated with nerve damage. NervGen Pharma Corp. was incorporated in 2017 and is headquartered in Vancouver, Canada.
Details
| Name | NervGen Pharma Corp. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 10 |
| Founded | 2017 |
| Ceo | Adam Rogers |
| Country | Canada |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| Isin | CA64082X2032 |
| Cusip | 64082X203 |
| Cik | 0001751912 |
Key executives
| Name | Title |
|---|---|
| Dr. Adam H. Rogers M.D. | President, Chief Executive Officer and Chairman |
| Dr. Harold Martin Punnett D.M.D. | Co-Founder and Independent Director |
| Dr. Randall E. Kaye M.D. | Chief Medical Advisor and Director |
| Dr. Keith A. Vendola M.B.A., M.D. | Chief Financial Officer |
| Dr. Charles V. Olson D.Sc. | Senior Vice President of Technical Operations |
| Shamim Ruff M.S. | Chief Regulatory Affairs Officer |
| Christine McSherry | Senior Vice President of Patient Advocacy and Clinical Affairs |
| Marissa Volpe | SVice President of Clinical Development |
Contact
| Address | 112-970 Burrard Street, Unit 1290, Vancouver, BC V6Z 2R4, Canada |
| Phone | 778 731 1711 |
| Website | https://nervgen.com |